Clinical Trials Directory

Trials / Completed

CompletedNCT01739959

Exploratory Study of Raised Serum Lactate as a Marker of Necrotizing Fasciitis

Raised Serum Lactate as a Marker of Necrotizing Fasciitis; a Consecutive Prospective Review.

Status
Completed
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
National Health Service, United Kingdom · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The investigators examined the hypothesis that serum lactate is raised in early necrotizing fasciitis to a much greater extent than in other differential diagnoses, such as severe cellulitis, and therefore provides a diagnostic indicator.

Detailed description

A prospective comparison of serum lactate levels at referral to the Plastic Surgery team to the 'gold standard' test of histology at initial surgical debridement, looking at 53 consecutive patients referred with suspected necrotizing fasciitis to a single surgeon at one institution between 2000 and 2010.

Conditions

Timeline

Start date
2000-09-01
Primary completion
2010-09-01
Completion
2010-09-01
First posted
2012-12-04
Last updated
2012-12-04

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01739959. Inclusion in this directory is not an endorsement.